...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Gasoline

KBC - no argument on the PFE data

TBRA - that was not a rumor, that was a CVR offer that was accepted. Over night the shares went up +/- 700% and then continued to go up a little from there. The point is the market cap of TBRA on the market was dramatically less than what Allergan was willing to pay which is where my thought is on both RVX and what many think Zenith is worth today.

Thank you for todays answer, much better than yesterdays.

What is the value you put on Zenith?

tada

Share
New Message
Please login to post a reply